_id
6915f507bc934aba376b22ff
Ticker
SCLX
Name
Scilex Holding Company
Exchange
NASDAQ
Address
960 San Antonio Road, Palo Alto, CA, United States, 94303
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
USD
Website
https://www.scilexholding.com
Description
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; and Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA. Scilex Holding Company is headquartered in Palo Alto, California.
Last Close
16.8
Volume
62366
Current Price
16.63
Change
-1.011904761904772
Last Updated
2025-12-03T13:24:31.452Z
Image
data:image/webp;base64,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
Ipo Date
2021-03-05T00:00:00.000Z
Market Cap
114884680
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8501538461538461
Sentiment Sources
26
Rating
4
Target Price
490.0005
Strong Buy
1
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
10560000
Cost Of Revenue
3329000
Gross Profit
7231000
Operating Expenses
193743000
Operating Income
-186512000
Interest Expense
2798000
Pretax Income
-257819000
Net Income
-257234000
Eps
-22.167700792830058
Dividends Per Share
-
Shares Outstanding
6127183
Income Tax Expense
-1000
EBITDA
-253998000
Operating Margin
-1766.2121212121215
Total Other Income Expense Net
-71307000
Cash
878000
Short Term Investments
-
Receivables
11941000
Inventories
1082000
Total Current Assets
16486999
Property Plant Equipment
2386000
Total Assets
275879000
Payables
67362000
Short Term Debt
55306000
Long Term Debt
-
Total Liabilities
455598000
Equity
-176936000
Depreciation
1023000
Change In Working Capital
-48726000
Cash From Operations
8230000
Capital Expenditures
300000
Cash From Investing
-152000
Cash From Financing
-11299000
Net Change In Cash
-3221000
PE
-
PB
-1.090645883257223
ROE
145.38251119048695
ROA
-93.24160229665904
FCF
7930000
Fcf Percent
0.7509469696969697
Piotroski FScore
2
Health Score
50
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
8.3
Garp Investing Score
4.5
Growth Investing Score
4.5
Momentum Investing Score
6.5
Net Net Investing Score
2
Quality Investing Score
4.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
10560000
Quarters > 0 > income Statement > cost Of Revenue
3329000
Quarters > 0 > income Statement > gross Profit
7231000
Quarters > 0 > income Statement > operating Expenses
193743000
Quarters > 0 > income Statement > operating Income
-186512000
Quarters > 0 > income Statement > interest Expense
2798000
Quarters > 0 > income Statement > pretax Income
-257819000
Quarters > 0 > income Statement > net Income
-257234000
Quarters > 0 > income Statement > eps
-22.167700792830058
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
11604000
Quarters > 0 > income Statement > income Tax Expense
-1000
Quarters > 0 > income Statement > EBITDA
-253998000
Quarters > 0 > income Statement > operating Margin
-1766.2121212121215
Quarters > 0 > income Statement > total Other Income Expense Net
-71307000
Quarters > 0 > balance Sheet > cash
878000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
11941000
Quarters > 0 > balance Sheet > inventories
1082000
Quarters > 0 > balance Sheet > total Current Assets
16486999
Quarters > 0 > balance Sheet > property Plant Equipment
2386000
Quarters > 0 > balance Sheet > total Assets
275879000
Quarters > 0 > balance Sheet > payables
67362000
Quarters > 0 > balance Sheet > short Term Debt
55306000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
455598000
Quarters > 0 > balance Sheet > equity
-176936000
Quarters > 0 > cash Flow > net Income
-257820000
Quarters > 0 > cash Flow > depreciation
1023000
Quarters > 0 > cash Flow > change In Working Capital
-48726000
Quarters > 0 > cash Flow > cash From Operations
8230000
Quarters > 0 > cash Flow > capital Expenditures
300000
Quarters > 0 > cash Flow > cash From Investing
-152000
Quarters > 0 > cash Flow > cash From Financing
-11299000
Quarters > 0 > cash Flow > net Change In Cash
-3221000
Quarters > 0 > ratios > PE
-22.167700792830058
Quarters > 0 > ratios > PB
-1.090645883257223
Quarters > 0 > ratios > ROE
145.38251119048695
Quarters > 0 > ratios > ROA
-93.24160229665904
Quarters > 0 > ratios > FCF
7930000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.7509469696969697
Quarters > 0 > health Score
50
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
9896000
Quarters > 1 > income Statement > cost Of Revenue
3272000
Quarters > 1 > income Statement > gross Profit
6624000
Quarters > 1 > income Statement > operating Expenses
27131000
Quarters > 1 > income Statement > operating Income
-20507000
Quarters > 1 > income Statement > interest Expense
2682000
Quarters > 1 > income Statement > pretax Income
-44029000
Quarters > 1 > income Statement > net Income
-86061000
Quarters > 1 > income Statement > eps
-7.422250970245796
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
11595000
Quarters > 1 > income Statement > income Tax Expense
19000
Quarters > 1 > income Statement > EBITDA
-40337000
Quarters > 1 > income Statement > operating Margin
-207.22514147130155
Quarters > 1 > income Statement > total Other Income Expense Net
-23522000
Quarters > 1 > balance Sheet > cash
4099000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
16767000
Quarters > 1 > balance Sheet > inventories
2519000
Quarters > 1 > balance Sheet > total Current Assets
33671000
Quarters > 1 > balance Sheet > property Plant Equipment
2573000
Quarters > 1 > balance Sheet > total Assets
83755000
Quarters > 1 > balance Sheet > payables
59155000
Quarters > 1 > balance Sheet > short Term Debt
40639000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
332742000
Quarters > 1 > balance Sheet > equity
-248987000
Quarters > 1 > cash Flow > net Income
-44048000
Quarters > 1 > cash Flow > depreciation
1010000
Quarters > 1 > cash Flow > change In Working Capital
21498000
Quarters > 1 > cash Flow > cash From Operations
7050000
Quarters > 1 > cash Flow > capital Expenditures
4.07
Quarters > 1 > cash Flow > cash From Investing
-153000
Quarters > 1 > cash Flow > cash From Financing
-8598000
Quarters > 1 > cash Flow > net Change In Cash
-1701000
Quarters > 1 > ratios > PE
-7.422250970245796
Quarters > 1 > ratios > PB
-0.7744374204275726
Quarters > 1 > ratios > ROE
34.56445517235839
Quarters > 1 > ratios > ROA
-102.75326846158438
Quarters > 1 > ratios > FCF
7049995.93
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.7124086428860146
Quarters > 1 > health Score
50
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
5004000
Quarters > 2 > income Statement > cost Of Revenue
1384000
Quarters > 2 > income Statement > gross Profit
3620000
Quarters > 2 > income Statement > operating Expenses
31518000
Quarters > 2 > income Statement > operating Income
-27898000
Quarters > 2 > income Statement > interest Expense
2481000
Quarters > 2 > income Statement > pretax Income
-26080000
Quarters > 2 > income Statement > net Income
-26080000
Quarters > 2 > income Statement > eps
-2.255079982706442
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
11565000
Quarters > 2 > income Statement > income Tax Expense
-1000
Quarters > 2 > income Statement > EBITDA
-22596000
Quarters > 2 > income Statement > operating Margin
-557.5139888089528
Quarters > 2 > income Statement > total Other Income Expense Net
1818000
Quarters > 2 > balance Sheet > cash
5800000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
10619000
Quarters > 2 > balance Sheet > inventories
3017000
Quarters > 2 > balance Sheet > total Current Assets
28704000
Quarters > 2 > balance Sheet > property Plant Equipment
2756000
Quarters > 2 > balance Sheet > total Assets
78976000
Quarters > 2 > balance Sheet > payables
57257000
Quarters > 2 > balance Sheet > short Term Debt
40182000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
290460000
Quarters > 2 > balance Sheet > equity
-211484000
Quarters > 2 > cash Flow > net Income
-26080000
Quarters > 2 > cash Flow > depreciation
1003000
Quarters > 2 > cash Flow > change In Working Capital
27228000
Quarters > 2 > cash Flow > cash From Operations
6007000
Quarters > 2 > cash Flow > capital Expenditures
150000
Quarters > 2 > cash Flow > cash From Investing
-395000
Quarters > 2 > cash Flow > cash From Financing
-3084000
Quarters > 2 > cash Flow > net Change In Cash
2528000
Quarters > 2 > ratios > PE
-2.255079982706442
Quarters > 2 > ratios > PB
-0.9094113502676325
Quarters > 2 > ratios > ROE
12.331902176996842
Quarters > 2 > ratios > ROA
-33.0226904376013
Quarters > 2 > ratios > FCF
5857000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
1.1704636290967225
Quarters > 2 > health Score
44
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
14900000
Quarters > 3 > income Statement > cost Of Revenue
4691000
Quarters > 3 > income Statement > gross Profit
10209000
Quarters > 3 > income Statement > operating Expenses
38587000
Quarters > 3 > income Statement > operating Income
-28378000
Quarters > 3 > income Statement > interest Expense
285000
Quarters > 3 > income Statement > pretax Income
-6461000
Quarters > 3 > income Statement > net Income
-6460000
Quarters > 3 > income Statement > eps
-0.929256267013589
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
6951796
Quarters > 3 > income Statement > income Tax Expense
-1000
Quarters > 3 > income Statement > EBITDA
-5172000
Quarters > 3 > income Statement > operating Margin
-190.4563758389262
Quarters > 3 > income Statement > total Other Income Expense Net
21917000
Quarters > 3 > balance Sheet > cash
3272000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
26442000
Quarters > 3 > balance Sheet > inventories
2436000
Quarters > 3 > balance Sheet > total Current Assets
41547000
Quarters > 3 > balance Sheet > property Plant Equipment
2933000
Quarters > 3 > balance Sheet > total Assets
92953000
Quarters > 3 > balance Sheet > payables
52620000
Quarters > 3 > balance Sheet > short Term Debt
35590000
Quarters > 3 > balance Sheet > long Term Debt
845000
Quarters > 3 > balance Sheet > total Liabilities
285594000
Quarters > 3 > balance Sheet > equity
-192641000
Quarters > 3 > cash Flow > net Income
-6460000
Quarters > 3 > cash Flow > depreciation
1004000
Quarters > 3 > cash Flow > change In Working Capital
9942000
Quarters > 3 > cash Flow > cash From Operations
2534000
Quarters > 3 > cash Flow > capital Expenditures
150000
Quarters > 3 > cash Flow > cash From Investing
-195000
Quarters > 3 > cash Flow > cash From Financing
-7183000
Quarters > 3 > cash Flow > net Change In Cash
-4844000
Quarters > 3 > ratios > PE
-0.929256267013589
Quarters > 3 > ratios > PB
-0.6001233770588815
Quarters > 3 > ratios > ROE
3.35338790807772
Quarters > 3 > ratios > ROA
-6.949748797779523
Quarters > 3 > ratios > FCF
2384000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.16
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
56590000
Annuals > 0 > income Statement > cost Of Revenue
16689000
Annuals > 0 > income Statement > gross Profit
39901000
Annuals > 0 > income Statement > operating Expenses
123297000
Annuals > 0 > income Statement > operating Income
-83396000
Annuals > 0 > income Statement > interest Expense
1963000
Annuals > 0 > income Statement > pretax Income
-72808000
Annuals > 0 > income Statement > net Income
-72807000
Annuals > 0 > income Statement > eps
-10.473120902857334
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
6951796
Annuals > 0 > income Statement > income Tax Expense
-1000
Annuals > 0 > income Statement > EBITDA
-66799000
Annuals > 0 > income Statement > operating Margin
-147.3687930729811
Annuals > 0 > income Statement > total Other Income Expense Net
10588000
Annuals > 0 > balance Sheet > cash
3272000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
26442000
Annuals > 0 > balance Sheet > inventories
2436000
Annuals > 0 > balance Sheet > total Current Assets
41547000
Annuals > 0 > balance Sheet > property Plant Equipment
2933000
Annuals > 0 > balance Sheet > total Assets
92953000
Annuals > 0 > balance Sheet > payables
52620000
Annuals > 0 > balance Sheet > short Term Debt
35590000
Annuals > 0 > balance Sheet > long Term Debt
845000
Annuals > 0 > balance Sheet > total Liabilities
285594000
Annuals > 0 > balance Sheet > equity
-192641000
Annuals > 0 > cash Flow > net Income
-72807000
Annuals > 0 > cash Flow > depreciation
4046000
Annuals > 0 > cash Flow > change In Working Capital
64839000
Annuals > 0 > cash Flow > cash From Operations
19349000
Annuals > 0 > cash Flow > capital Expenditures
600000
Annuals > 0 > cash Flow > cash From Investing
-2675000
Annuals > 0 > cash Flow > cash From Financing
-18131000
Annuals > 0 > cash Flow > net Change In Cash
-1457000
Annuals > 0 > ratios > PE
-10.473120902857334
Annuals > 0 > ratios > PB
-0.6777099832330605
Annuals > 0 > ratios > ROE
37.79413520486293
Annuals > 0 > ratios > ROA
-78.32668122599593
Annuals > 0 > ratios > FCF
18749000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.3313129528185192
Annuals > 0 > health Score
50
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
46743000
Annuals > 1 > income Statement > cost Of Revenue
15681000
Annuals > 1 > income Statement > gross Profit
31062000
Annuals > 1 > income Statement > operating Expenses
136493000
Annuals > 1 > income Statement > operating Income
-105431000
Annuals > 1 > income Statement > interest Expense
1068000
Annuals > 1 > income Statement > pretax Income
-114318000
Annuals > 1 > income Statement > net Income
-114331000
Annuals > 1 > income Statement > eps
-30.712558433401906
Annuals > 1 > income Statement > dividends Per Share
10000000
Annuals > 1 > income Statement > shares Outstanding
3722614
Annuals > 1 > income Statement > income Tax Expense
13000
Annuals > 1 > income Statement > EBITDA
-109104000
Annuals > 1 > income Statement > operating Margin
-225.55462850052413
Annuals > 1 > income Statement > total Other Income Expense Net
-8887000
Annuals > 1 > balance Sheet > cash
3921000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
34597000
Annuals > 1 > balance Sheet > inventories
4214000
Annuals > 1 > balance Sheet > total Current Assets
46781000
Annuals > 1 > balance Sheet > property Plant Equipment
3665000
Annuals > 1 > balance Sheet > total Assets
101309000
Annuals > 1 > balance Sheet > payables
40954000
Annuals > 1 > balance Sheet > short Term Debt
109188000
Annuals > 1 > balance Sheet > long Term Debt
17038000
Annuals > 1 > balance Sheet > total Liabilities
274247000
Annuals > 1 > balance Sheet > equity
-172938000
Annuals > 1 > cash Flow > net Income
-114331000
Annuals > 1 > cash Flow > depreciation
4146000
Annuals > 1 > cash Flow > change In Working Capital
65802000
Annuals > 1 > cash Flow > cash From Operations
-20707000
Annuals > 1 > cash Flow > capital Expenditures
330000
Annuals > 1 > cash Flow > cash From Investing
-330000
Annuals > 1 > cash Flow > cash From Financing
23582000
Annuals > 1 > cash Flow > net Change In Cash
2545000
Annuals > 1 > ratios > PE
-30.712558433401906
Annuals > 1 > ratios > PB
-0.404252916767859
Annuals > 1 > ratios > ROE
66.11097618799802
Annuals > 1 > ratios > ROA
-112.85374448469534
Annuals > 1 > ratios > FCF
-21037000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.45005669298076717
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
38034000
Annuals > 2 > income Statement > cost Of Revenue
10797000
Annuals > 2 > income Statement > gross Profit
27237000
Annuals > 2 > income Statement > operating Expenses
77871000
Annuals > 2 > income Statement > operating Income
-50634000
Annuals > 2 > income Statement > interest Expense
9604000
Annuals > 2 > income Statement > pretax Income
-23360000
Annuals > 2 > income Statement > net Income
-23364000
Annuals > 2 > income Statement > eps
-6.092566646248589
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3834837
Annuals > 2 > income Statement > income Tax Expense
4000
Annuals > 2 > income Statement > EBITDA
-9303000
Annuals > 2 > income Statement > operating Margin
-133.12825366777093
Annuals > 2 > income Statement > total Other Income Expense Net
27274000
Annuals > 2 > balance Sheet > cash
2184000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
21236000
Annuals > 2 > balance Sheet > inventories
1378000
Annuals > 2 > balance Sheet > total Current Assets
29608000
Annuals > 2 > balance Sheet > property Plant Equipment
1903000
Annuals > 2 > balance Sheet > total Assets
86527000
Annuals > 2 > balance Sheet > payables
8450000
Annuals > 2 > balance Sheet > short Term Debt
745000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
50288000
Annuals > 2 > balance Sheet > equity
36239000
Annuals > 2 > cash Flow > net Income
-23364000
Annuals > 2 > cash Flow > depreciation
3961000
Annuals > 2 > cash Flow > change In Working Capital
45668000
Annuals > 2 > cash Flow > cash From Operations
-21258000
Annuals > 2 > cash Flow > capital Expenditures
2067000
Annuals > 2 > cash Flow > cash From Investing
-2067000
Annuals > 2 > cash Flow > cash From Financing
21171000
Annuals > 2 > cash Flow > net Change In Cash
-2154000
Annuals > 2 > ratios > PE
-6.092566646248589
Annuals > 2 > ratios > PB
1.987313084246254
Annuals > 2 > ratios > ROE
-64.47197770357901
Annuals > 2 > ratios > ROA
-27.001976261744886
Annuals > 2 > ratios > FCF
-23325000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.6132670768259978
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
31317000
Annuals > 3 > income Statement > cost Of Revenue
3634000
Annuals > 3 > income Statement > gross Profit
27683000
Annuals > 3 > income Statement > operating Expenses
63521000
Annuals > 3 > income Statement > operating Income
-35838000
Annuals > 3 > income Statement > interest Expense
11764000
Annuals > 3 > income Statement > pretax Income
-88419000
Annuals > 3 > income Statement > net Income
-88424000
Annuals > 3 > income Statement > eps
-23.295509481254445
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3795753
Annuals > 3 > income Statement > income Tax Expense
5000
Annuals > 3 > income Statement > EBITDA
-72876000
Annuals > 3 > income Statement > operating Margin
-114.43624868282403
Annuals > 3 > income Statement > total Other Income Expense Net
-52581000
Annuals > 3 > balance Sheet > cash
4338000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
14268000
Annuals > 3 > balance Sheet > inventories
2562000
Annuals > 3 > balance Sheet > total Current Assets
23003000
Annuals > 3 > balance Sheet > property Plant Equipment
2108000
Annuals > 3 > balance Sheet > total Assets
77932000
Annuals > 3 > balance Sheet > payables
4284000
Annuals > 3 > balance Sheet > short Term Debt
58058000
Annuals > 3 > balance Sheet > long Term Debt
3834699
Annuals > 3 > balance Sheet > total Liabilities
301808000
Annuals > 3 > balance Sheet > equity
-223876000
Annuals > 3 > cash Flow > net Income
-88424000
Annuals > 3 > cash Flow > depreciation
3779000
Annuals > 3 > cash Flow > change In Working Capital
13602000
Annuals > 3 > cash Flow > cash From Operations
-28664000
Annuals > 3 > cash Flow > capital Expenditures
7000
Annuals > 3 > cash Flow > cash From Investing
-139380000
Annuals > 3 > cash Flow > cash From Financing
28163000
Annuals > 3 > cash Flow > net Change In Cash
-501000
Annuals > 3 > ratios > PE
-23.295509481254445
Annuals > 3 > ratios > PB
-0.318409482660044
Annuals > 3 > ratios > ROE
39.496864335614355
Annuals > 3 > ratios > ROA
-113.46301904224197
Annuals > 3 > ratios > FCF
-28671000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.9155091483858607
Annuals > 3 > health Score
30
Valuation > metrics > PE
-22.167700792830058
Valuation > metrics > PB
-1.090645883257223
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
145.38251119048695
Profitability > metrics > ROA
-1560.2233007959787
Profitability > metrics > Net Margin
-24.359280303030303
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-66.6590421729807
Risk > final Score
-237
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.13440342224541038
Liquidity > metrics > Quick Ratio
0.12558286594710927
Liquidity > final Score
16
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
25
Prev Profitabilities > 2
7
Prev Risks > 0
-1
Prev Risks > 1
-15
Prev Risks > 2
-368
Prev Liquidities > 0
26
Prev Liquidities > 1
23
Prev Liquidities > 2
32
Updated At
2025-12-14T01:09:05.664Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-22.17
Earnings History > 0 > eps Estimate
-0.12
Earnings History > 0 > eps Difference
-22.05
Earnings History > 0 > surprise Percent
-18375
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-7.42
Earnings History > 1 > eps Estimate
-0.12
Earnings History > 1 > eps Difference
-7.3
Earnings History > 1 > surprise Percent
-6083.3333
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-2.26
Earnings History > 2 > eps Estimate
-0.12
Earnings History > 2 > eps Difference
-2.14
Earnings History > 2 > surprise Percent
-1783.3333
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-2.98
Earnings History > 3 > eps Estimate
-0.14
Earnings History > 3 > eps Difference
-2.84
Earnings History > 3 > surprise Percent
-2028.5714
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-27
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-1.365
Earnings History > 4 > eps Estimate
-3.5
Earnings History > 4 > eps Difference
2.135
Earnings History > 4 > surprise Percent
61
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-28
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-9.1683
Earnings History > 5 > eps Estimate
-4.9
Earnings History > 5 > eps Difference
-4.2683
Earnings History > 5 > surprise Percent
-87.1082
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-13
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.24
Earnings History > 6 > eps Estimate
-0.1
Earnings History > 6 > eps Difference
-0.14
Earnings History > 6 > surprise Percent
-140
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-12
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.25
Earnings History > 7 > eps Estimate
-0.23
Earnings History > 7 > eps Difference
-0.02
Earnings History > 7 > surprise Percent
-8.6957
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.63
Earnings History > 8 > eps Estimate
-0.17
Earnings History > 8 > eps Difference
-0.46
Earnings History > 8 > surprise Percent
-270.5882
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-6.5396
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-12
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.22
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-07
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.13
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-04
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.01
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.12
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.05
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.07
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.08
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-07-23
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.08
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-03-31
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
2.6962
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-15
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; and Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA. Scilex Holding Company is headquartered in Palo Alto, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIs SCLX a good long term investment - Stock Rotation Strategies & Interactive Charts for Smarter Trading earlytimes.in
Read more →Datavault AI (NASDAQ: DVLT) Sets Dec. 24 Distribution Date for Dream Bowl 2026 Meme Coin The Globe and Mail
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$490.0005
Analyst Picks
Strong Buy
1
Buy
0
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 14.20% of the total shares of Scilex Holding Company
1.
Vanguard Group Inc(4.2313%)
since
2025/06/30
2.
Vanguard Total Stock Mkt Idx Inv(2.2848%)
since
2025/07/31
3.
BlackRock Inc(1.9025%)
since
2025/06/30
4.
Geode Capital Management, LLC(0.889%)
since
2025/06/30
5.
Vanguard Institutional Extnd Mkt Idx Tr(0.7161%)
since
2025/07/31
6.
Vanguard Balanced Index Inv(0.6374%)
since
2025/07/31
7.
Fidelity Extended Market Index(0.351%)
since
2025/07/31
8.
UBS Group AG(0.2649%)
since
2025/06/30
9.
Morgan Stanley - Brokerage Accounts(0.2596%)
since
2025/06/30
10.
Rafferty Asset Management, LLC(0.2547%)
since
2025/06/30
11.
NORGES BANK(0.1962%)
since
2025/06/30
12.
Quantinno Capital Management LP(0.1936%)
since
2025/06/30
13.
Citadel Advisors Llc(0.182%)
since
2025/06/30
14.
BlackRock Advantage Small Cap Core Instl(0.1767%)
since
2025/07/31
15.
iShares Micro-Cap ETF(0.1756%)
since
2025/08/31
16.
State Street Corp(0.1709%)
since
2025/06/30
17.
Extended Equity Market Fund K(0.1497%)
since
2025/06/30
18.
Bank of America Corp(0.1381%)
since
2025/06/30
19.
Fidelity Total Market Index(0.123%)
since
2025/07/31
20.
Belfund SICAV Belinvest Equity A USD Acc(0.1147%)
since
2025/07/31
21.
T. Rowe Price Extended Equity Market Idx(0.1035%)
since
2025/07/31
22.
Fidelity Series Total Market Index(0.0875%)
since
2025/07/31
23.
Barclays PLC(0.0803%)
since
2025/06/30
24.
Spartan Extended Market Index Pool F(0.0769%)
since
2025/07/31
25.
Northern Trust Extended Eq Market Idx(0.0739%)
since
2025/06/30
26.
NT Ext Equity Mkt Idx Fd - L(0.0739%)
since
2025/06/30
27.
NT Ext Equity Mkt Idx Fd - NL(0.0606%)
since
2025/06/30
28.
Fidelity Small Cap Index(0.0597%)
since
2025/06/30
29.
NT Col R2000 Val Idx Fd -DC -L -TierFour(0.0434%)
since
2025/03/31
30.
BNP Paribas Arbitrage, SA(0.0369%)
since
2025/06/30
31.
State Street Russell 2000 Value CIT(0.0189%)
since
2025/03/31
32.
MetLife Investment Management, LLC(0.0157%)
since
2025/06/30
33.
Royal Bank of Canada(0.0132%)
since
2025/06/30
34.
Deutsche Bank AG(0.0115%)
since
2025/06/30
35.
Versant Capital Management Inc(0.0109%)
since
2025/06/30
36.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0107%)
since
2024/12/31
37.
Activest Wealth Management(0.0043%)
since
2025/06/30
38.
SSgA U.S. Total Market Index Strategy(0.004%)
since
2025/03/31
39.
Wells Fargo & Co(0.0037%)
since
2025/06/30
40.
Van Eck Associates Corporation(0.0007%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-22.17
EPS Estimate
-0.12
EPS Difference
-22.05
Surprise Percent
-18375%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.